Pancreatic Cancer Research

ResearcherHudson Institute of Medical ResearchActive in the last 2 years

Vinod Ganju

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4713-7752; OpenAlex author ID A5018587056. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer. Co-author DOI 10.1038/s41416-025-03286-w↗
  2. Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C inhibitors. Co-author DOI 10.3389/fonc.2025.1691760↗
  3. Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells. Co-author DOI 10.1158/1078-0432.ccr-23-1821↗
  4. Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and L… Last author DOI 10.1200/po.21.00437↗
  5. Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with meta… Co-author DOI 10.1634/theoncologist.2014-0394↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Owen McKay · 2 shared papers, 2022–2025 · strength 0.55
  2. Daniel Gerald Croagh · 2 shared papers, 2022–2025 · strength 0.55
  3. Saeed Aslani · 1 shared paper, 2025 · strength 0.33
  4. Xinfang Hou · 1 shared paper, 2026 · strength 0.24
  5. Jianzhen Shan · 1 shared paper, 2026 · strength 0.24
  6. Noboru Yamamoto · 1 shared paper, 2026 · strength 0.24
  7. Dong Yan · 1 shared paper, 2026 · strength 0.24
  8. Rui‐Hua Xu · 1 shared paper, 2026 · strength 0.24
  9. Himanshu N. Brahmbhatt · 1 shared paper, 2024 · strength 0.23
  10. Joanne Lundy · 1 shared paper, 2022 · strength 0.22
  11. Alfredo Romano · 1 shared paper, 2015 · strength 0.04
  12. Werner Scheithauer · 1 shared paper, 2015 · strength 0.04
  13. David Goldstein · 1 shared paper, 2015 · strength 0.04
  14. Josep M. Tabernero · 1 shared paper, 2015 · strength 0.04
  15. Ramesh K. Ramanathan · 1 shared paper, 2015 · strength 0.04
  16. Jeffrey R. Infante · 1 shared paper, 2015 · strength 0.04
  17. Colin D. Weekes · 1 shared paper, 2015 · strength 0.04
  18. Sunil R. Hingorani · 1 shared paper, 2015 · strength 0.04
  19. Elena Gabriela Chiorean · 1 shared paper, 2015 · strength 0.04
  20. Daniel D. Von Hoff · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.